CIK 0000882095 · Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943047598
- Phone
- 6505743000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $35,234,659
- in 11 filings, $35.2M under 10b5-1 plans
Net −$35,234,659. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- O'Day Daniel Patrick −$29.5M Chairman & CEO sold 24% of stake
- WELTERS ANTHONY −$2.7M Director sold 58% of stake
- Dickinson Andrew D −$905K Chief Financial Officer sold 4% of stake
- Mercier Johanna −$901K Chief Comm & Corp Aff Officer sold 5% of stake
- Bluestone Jeffrey −$725K Director sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-30 | WELTERS ANTHONY Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +4,884 | 4,884 | ||
| 2026-04-30 | LOVE TED W Director | Grant or award | +1,146 | 5,484 | ||
| 2026-04-30 | LOVE TED W Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +4,884 | 4,884 | ||
| 2026-04-30 | BARTON JACQUELINE K Director | Grant or award | +1,146 | 27,202 | ||
| 2026-04-30 | BARTON JACQUELINE K Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +4,884 | 4,884 | ||
| 2026-04-30 | Bluestone Jeffrey Director | Grant or award | +1,146 | 10,066 | ||
| 2026-04-30 | Bluestone Jeffrey Director | Grant or award · Non-qualified Stock Option (Right to Buy) | +4,884 | 4,884 | ||
| 2026-04-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −6,950 | $128.79 | $895K | 635,617 |
| 2026-04-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −3,050 | $130.01 | $397K | 632,567 |
| 2026-04-15 | Mercier Johanna Chief Comm & Corp Aff Officer | Sale 10b5-1 | −3,000 | $140.96 | $423K | 128,779 |
| 2026-04-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −3,000 | $140.96 | $423K | 176,191 |
| 2026-03-27 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −10,000 | $136.82 | $1.4M | 642,567 |
| 2026-03-16 | Mercier Johanna Chief Comm & Corp Aff Officer | Sale 10b5-1 | −3,000 | $144.23 | $433K | 131,779 |
| 2026-03-16 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −3,000 | $144.23 | $433K | 179,191 |
| 2026-03-10 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Option exercise | +1,246 | 5,660 | ||
| 2026-03-10 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Shares withheld for taxes | −606 | $148.56 | $90K | 5,054 |
| 2026-03-10 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Option exercise · Restricted Stock Unit | −1,246 | 15,536 | ||
| 2026-03-10 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Grant or award · Restricted Stock Unit | +5,050 | 20,586 | ||
| 2026-03-10 | Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp | Grant or award · Non-qualified Stock Option (Right to Buy) | +18,885 | 18,885 | ||
| 2026-03-10 | Burkhart Erin SVP, Controllership | Grant or award · Restricted Stock Unit | +2,355 | 11,245 |
Page 7 of 30 · 584 trades